Skip to content

Rafael Holdings, Inc. RFL Exchanges Ratio With Cyclo Merger

Exchanges Ratio With Cyclo Merger at other companies

RDI
Reading International, Inc.RDI
10.0%
Rein Therapeutics, Inc. Common Stock logo
Rein Therapeutics, Inc. Common StockRNTX
$0
Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
$1.02M+687,316%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$52.83M
Blaize Holdings, Inc. Common Stock logo
Blaize Holdings, Inc. Common StockBZAI
$0-100%
Emerald Holding logo
Emerald HoldingEEX
$0-100%

Other financials

Income statement

See full
Revenue$179.0K-50.6%
Gross profit$131.0K-56.3%
Operating income-$6.9M-16.2%
Net income-$4.2M+11.6%
EPS (diluted)-$0.08+57.9%

Balance sheet

See full
Cash & equivalents$30.5M-19.6%
Total debt$21.9M+995%
Total equity$75.4M-6.4%
Total assets$92.0M-14.9%

Cash flow

See full
Operating cash flow-$7.3M-128%
CapEx$6.0K
Free cash flow-$7.3M-128%

Valuation

See full
Market cap$170.56M+189%
P/S174×+93.5×

Profitability

See full
Gross margin71.9%
Operating margin-3,717.2%+1,952pp
Net margin-2,117.2%-517pp
FCF margin-2,064.1%

Returns & leverage

See full
Return on equity-26.6%-0.8pp
Debt / equity0.3×+0.2×
Current ratio3.2×-0.7×

Where this comes from

Reported directly by Rafael Holdings, Inc. in its filing.

Tagged under the XBRL concept rfl:ExchangesRatioWithCycloMerger.

The official record: Rafael Holdings, Inc.’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rafael Holdings, Inc.'s exchanges ratio with cyclo merger.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rafael Holdings, Inc.'s exchanges ratio with cyclo merger?
Rafael Holdings, Inc. (RFL) reported exchanges ratio with cyclo merger of 0.4 in Q1 2025.
What does exchanges ratio with cyclo merger mean?
Defines the conversion rate at which the company's securities or assets were exchanged for those of a merger partner. This ratio is a critical indicator of the valuation terms agreed upon during a business combination. It allows investors to assess the relative value assigned to the company's equity during strategic transactions.